No Data
No Data
Zhongtai Securities: Steady performance under the influence of policies and fundamentals, grasping investment opportunities driven by medical device innovation+ inflection points
The medical device industry continues to grow rapidly. It is optimistic about importation substitution and global development driven by innovation. Volume procurement policies will continue to be implemented, medical anti-corruption is expected to ease, and sector valuations are expected to gradually recover.
Chunli Medical's net profit of 55,1996 million yuan in the first quarter decreased by 1.18% year-on-year
Chunli Medical (01858) released its report for the first quarter of 2024, with operating income of 222 million yuan (RMB, same below), down 9.95% year on year; net profit attributable to shareholders of listed companies was 55,1996 million yuan, down 1.18% year on year; basic earnings per share were 0.14 yuan.
春立醫療:2024年第一季度報告
春立醫療:2023 年報
Chunli Medical (688236.SH) announced first-quarter results, net profit of 55.2 million yuan, a year-on-year decrease of 1.18%
Chunli Medical (688236.SH) disclosed its report for the first quarter of 2024. The company achieved revenue of 2.2 during the reporting period...
Chunli Medical (01858.HK) plans to hold a board meeting on April 29 to approve the first quarter results
Gelonghui, April 17, 丨 Chunli Healthcare (01858.HK) issued an announcement. The board of directors will hold a board meeting on April 29, 2024 (Monday) to approve (among others) the announcement of the first quarter results of the company and its subsidiaries for the three months ended March 31, 2024 and consider paying an interim dividend (if any).
No Data